L. E. Jennings et al.
a molybdenum reductant (8501C) and delivered to the hot cell.
[8] a) S. Lu, J. Hong, V. W. Pike, J. Label. Compd. Radiopharm. 2003,
46, 1249–1259; b) A. A. Wilson, A. Garcia, S. Houle, N. Vasdev, Org.
Biomol. Chem. 2010, 8(2), 428–432; c) J. M. Hooker, A. T. Reibel,
S. M. Hill, M. J. Schueller, J. S. Fowler, Angew. Chem. Int. Ed. 2009,
48, 3482–3485.
Unconverted [11C]CO2 was collected on an ascarite trap.
General radiolabelling procedure
[9] S. Kealey, P. W. Miller, N. J. Long, C. Plisson, L. Martarello,
A. D. Gee, Chem. Commun. 2009, 3696–3698.
[10] H. Audrain, L. Martarello, A. Gee, D. Bender, Chem. Commun.
2004, 558–559.
Ã
CuCl (11 mmol, 1.1 mg, 1 eq.) and KTp (11 mmol, 3.7 mg, 1 eq.)
was weighed into a 5 mL glass vial and placed under a N2
atmosphere. Dry THF (1 mL) was added to form the trapping
solution. A [11C]CO/He gas stream was delivered to the vial,
forming the CuTp [11C]CO complex. Following this, the cross-
˚
[11] P. Lidstrom, T. Kihlberg, B. Langstrom, J. Chem. Soc. Perkin Trans.
¨
Ã
1997, 1, 2701–2706.
[12] F. Karimi, J. Barletta, B. Langstrom, Eur. J. Org. Chem. 2005, 2374–2378.
˚
[13] O. Rahman, J. Llop, B. Langstrom, Eur. J. Org. Chem. 2004,
¨
coupling reagents (Pd2(dba)3 (1.01 mg, 1.1 mmol, 20 mol %),
IMes.HCl (0.75 mg, 2.2 mmol, 20 mol %), iodobenzene (2.3 mg,
11 mmol, 1 eq.), benzylamine (0.1 mL, excess) and triphenylphos-
phine (5.8 mg, 22 mmol, 2 eq.) in 0.9 mL DMF) were added to the
vial using an Argon gas sweep. The vial was sealed and the
mixture heated for 10 min after which time it was quenched by
addition of 1 mL NH4OAc (pH 4.9) under an Argon gas sweep.
Finally, the radioactivity of the reaction vial was measured and
the crude mixture analysed by analytical HPLC. The reaction
mixture was analysed on an analytical radio HPLC (Agilent 1100,
60:40 water:acetonitrile, flow rate 1.5 mL/min, fitted with an
Agilent Eclipse XDBC18, 5 mm, 4.6 ꢀ 150 mm column). During
each step the radioactivity of the waste gases was measured in
order to calculate incorporation of [11C]CO and radiochemical
˚
¨
2674–2678.
[14] O. Rahman, B. Langstrom, J. Label. Compd. Radiopharm. 2007, 50,
1192–1199.
˚
¨
˚
[15] T. Kihlberg, B. Langstro¨m, J. Org. Chem. 1999, 64(25), 9201–9205.
˚
[16] K. Farhad, B. Langstrom, Org. Biomol. Chem. 2003, 1(3), 541–546.
[17] B. Langstrom, O. Itsenko, O. Rahman, J. Labelled Compd.
¨
˚
¨
Radiopharm. 2007, 50(9), 794–810.
[18] Methods and Apparatus for Production and Use of [11C]Carbon
Monoxide in labelling Synthesis: International patent application,
˚
T. Kihlberg, B. Langstrom, T. Ferm, J. Eriksson, PCT/IB2005/
¨
001939, 2005.
[19] E. D. Hostetler, H. D. Burns, Nucl. Med. Biol. 2002, 29(8), 845–848.
[20] R. Singh, S. P. Nolan, Annu. Rep. Prog. Chem. Sect. B 2006, 102,
168–196.
[21] E. B. Kantchev, C. J. O’Brien, M. G. Organ, Angew. Chem. Int. Ed.
2007, 46, 2768–2813.
yields based on the starting radioactivity of the CuTp [11C]CO
Ã
[22] W. A. Hermann, C. Kocher, Angew. Chem. Int. Ed. Eng. 1997, 36,
2162–2187.
solution.
[23] C. Zhang, J. Huang, M. L. Trudell, S. P. Nolan, J. Org. Chem. 1999,
64, 3804–3805.
[24] Z. H. Chohan, M. Praveen, Appl. Organomet. Chem. 2001, 15(17),
617–625.
Acknowledgements
P.W.M. and L.E.J. are grateful to the EPSRC for the award of a Life
Sciences Interface Fellowship (EP/E039278/1) and
[25] S. Caddick, F. G. N. Cloke, P. B. Hitchcock, J. Leonard, A. K. de
K. Lewis, D. McKerrecher, L. R. Titcomb, Organometallics 2002, 21,
4318–4319.
[26] E. Maerten, M. Sauthier, A. Mortreux, Y. Castanet, Tetrahedron
2007, 63, 682–689.
a DTA
Studentship respectively. The Leverhulme Trust is thanked for
the award of a Research Fellowship (4/RFG/2009/0493) to N.J.L.
[27] M. B. Andrus, Y. Ma, Y. Zang, C. Song, Tetr. Lett. 2002, 43,
9137–9140.
[28] S. Zheng, F. Li, J. Liu, C. Xia, Tetr. Lett. 2007, 48, 5883–5886.
[29] A. S. Veige, Polyhedron 2008, 27, 3177–3189.
[30] Y. Ma, C. Song, Q. Chai, C. Ma, M. B. Andrus, Synthesis 2003, 18,
2886–2889.
[31] V. Calo, P. Giannoccaro, A. Nacci, A. Monopoli, J. Organomet.
Chem. 2002, 645(1–2), 152–157.
References
[1] M. E. Phelps, Proc. Natl. Acad. Sci. 2000, 97(16), 9226–9233.
[2] R. L. Wahl, Principles and Practice of PET and PET/CT, 2nd ed.,
Lippincott Williams & Wilkins, Philadelphia, PA, 2009.
[3] P. W. Miller, N. J. Long, R. Vilar, A. D. Gee, Angew. Chem. Int. Ed.
2008, 47, 8998–9033.
[32] Z. Freixa, P. W. N. M. Van Leeuwen, J. Chem. Soc., Dalton Trans.
2003, 10, 1890–1901.
[4] a) R. Bolton, J. Label. Compd. Radiopharm, 2001, 44(10), 701–736;
b) F. Wuest, M. Berndt, T. Kniess, Carbon-11 labelling chemistry
based upon [11C]methyl iodide, Ernst Schering Research Founda-
tion Workshop, Vol. 62 (Eds.: Schubiger, P.August; Lehmann, Lutz;
Friebe, Matthias), 2006, pp. 183–213.
[33] P. W. Miller, L. E. Jennings, A. J. deMello, A. D. Gee, N. J. Long,
R. Vilar, Adv. Synth. Catal. 2009, 351(18), 3260–3268.
[34] C. F. J. Barnard, Organometallics 2008, 27, 5402–5422.
[35] S. Diez-Gonzalez, S. P. Nolan, Coord. Chem. Rev. 2007, 251, 874–883.
[36] R. A. III Kelly, H. Clavier, S. Giudice, N. M. Scott, E. D. Stevens,
J. Bordner, I. Samardjiev, C. D. Hoff, L. Cavallo, S. P. Nolan,
Organometallics 2008, 27, 202–210.
[5] D. M. Jewett, Appl. Radiat. Isot. 1992, 43(11), 1383–1385.
[6] W. E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist,
¨
D. P. Holt, M. Bergstrom, I. Savitcheva, G. Huang, S. Estrada,
B. Ausen, M. L. Debnath, J. Barletta, J. C. Price, J. Sandell,
¨
¨
[37] V. W. P. Bohm, C. W. K. Gstottmayr, T. Weskamp, W. A. Herrmann,
J. Orgamomet. Chem. 2000, 595, 186–190.
´
˚
[38] T. Kihlberg, B. Langstrom, PCT Int. Appl. WO, 2 002 102 711 A1,
¨
B. J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C. A. Mathis,
˚
¨
B. Langstrom, Ann. Neurol. 2004, 55(3), 306–319.
2002, 559.
˚
[7] P. W. Miller, N. J. Long, A. J. de Mello, R. Vilar, H. Audrain, D. Bender,
J. Passchier, A. Gee, Angew. Chem. Int. Ed. 2007, 46, 2875–2878.
[39] O. Rahman, T. Kihlberg, B. Langstro¨m, Eur. J. Org. Chem. 2004,
474–478.
J. Label Compd. Radiopharm 2011, 54 135–139
Copyright r 2010 John Wiley & Sons, Ltd.